|
|
 |
Myoview™ | | | General Information | |
| Vendor | | Amersham Health | | Item | | Myoview™ | | Approval | | US FDA | | Product Number | | Inquire | | Type of Isotope | | Technetium 99m | | Pricing |  | Inquire | | Financing | | To finance this purchase click here (U.S. customers only) |
| | Product Description | |
| A cardiac imaging agent that is labeled with technetium 99m, MYOVIEW is useful in the diagnosis and localization of regions of reversible myocardial ischemia in the presence or absence of infarction under exercise and rest conditions. Imaging can begin as soon as 15 minutes or up to 4 hours after administration of MYOVIEW, enhancing patient management and department flexibility. The product was approved by the FDA in February 1996.
| |
| Amersham Health | | Customer Service: (800) 654-0118 | | Web site: http://www.amershamhealth-us.com/ | |
| NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary. |
|
|
